chrisvoncsefalvay/vaers-outcomes huggingface dataset:
neck pain (base of skull); neck stiffness; nausea; hot flashes; general fatigue; feeling unwell; sick; This is a spontaneous report from a non-contactable consumer (patient). A 22-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at time of vaccination. The patient was previously vaccinated with first dose of  BNT162B2 on unspecified date at single use for COVID-19 immunization. The patient experienced neck pain (base of skull) / neck stiffness, nausea, hot flashes, general fatigue, feeling "unwell" and was sick on an unspecified date. The outcome of the events was recovered on unspecified date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events were considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, were not disabling/Incapacitating and were not a congenital anomaly/birth defect.  No follow-up attempts are possible. No further information is expected.
Flu like symptoms for 3-4 days, fluctuating nerve pain especially around joints, knees and ankles. Swollen lymph node near armpit. Muscle fatigue. Started right side groin pain today.
After being exposed to COVID-19 took Home test and was positive; Tested positive for COVID-19 on 12/17/2022; Was prescribed Paxlovid; Tested negative for COVID-19 on 5th day, was feeling better; Then 10 days later rebounded and tested positive again for COVID-19 with a home test; Took another Home COVID-19 test 5 days later and tested negative.
approximately 6 hours after shot,arm very swollen and sore started getting chills, fever, headache felt nauseaus and felt kind of dizzy, chills got worse within couple hours and breating labored, also heartbeat very rapid this lasted for about 7 hours before finally subsiding into slight congestion low grade fever and runny nose and arm still a little sore
About 6 hrs after receiving the Pfizer-BioTech COVID-19 Vaccine my left arm was sore and my left leg, from the knee down was very achy, along with some swelling behind my knee.  The next morning my leg did not ache but was very tender to touch, swollen and as of today (3 days later) it is still tender and swollen.
Redness (size of silver dollar), tenderness and swelling at injection site occurred  immediately after injection.  Redness and tenderness went away after 3 days, however lump at injection site remained.  Redness and skin irritation suddenly appeared 2 weeks after injection along with slight chill sensation up and down arm.  Skin around injection site is very sensitive to touch.  I can see exactly where the injection was given 2 weeks ago as the needle entrance point is red.  I have applied Benadryl spray to the injection site and applied a bandage to prevent irritation from clothing rubbing site.
This spontaneous report as received from a Certified Medical Assistant (C.M.A) refers to a patient of unknown age and gender. No pertinent medical history or drug reactions/allergies were provided. The medical assistant reported that the patient was administered first dose of GARDASIL INJ, 0.5 ml, intramuscular (lot number not provided), on 24-MAY-2013, and the second dose of GARDASIL, 0.5 ml, intramuscular (lot number not provided), on 14-APR-2014, No adverse effects reported. Additional information has been requested.
my knee pain after vaccine shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (my knee pain after vaccine shot) in a 72-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concomitant products included Losartan 50mg and blood thinner for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (my knee pain after vaccine shot). At the time of the report, ARTHRALGIA (my knee pain after vaccine shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were not provided by the reporter.    Reporter did not allow further contact
As per mom info pt was fine 1-4FEB; on Sat & sun c/o stomachache & back pain below the waist; On Monday 7FEB was taken to MD office c/o tingling & numbness to rt legs; unable to walk;
Myalgia Day 2, body aches, chills fatigue for 2 days. Day 2, large welt until day 7. Narrative:  Other Relevant History:
PATIENT HAD NAUSEA & DIARRHEA 8 DAYS AFTER HER SECOND COVID VACCINE.  ON 4/20/21 SHE DEVELOPED A PETECHEAL RASH ON HER LEGS THAT GRADUALLY SPREAD UP HER LEGS & TO ABDOMEN. NO OTHER SYMPTOMS.
Missed abortion Date of last period December 1, 2020 (34 day cycle) Fetus measured 6 weeks and 4 days on 2/12/2021, but I was expected to be at 9 weeks 4 days. No heart beat. Therefore, estimated date of fetal demise is 1/22/2021 First pregnancy, estimated date of delivery 09/13/2021 Scheduled for D&E on 2/17/2021
04/11/2022 Vaccination 07/10/2022 I experienced coughing mid morning. I did a test at home that day COVID-19 NEGATIVE. Symptoms worsened to congestion, body aches, fatigue, sore throat.  07/11/2022 I did a PCR test and it was COVID-19+ Tessalon Perles prescribed by Doctor.  Waiting to see if they are going to push for the anti viral medication.
Initial misuse case was received from a healthcare professional on 23 SEP 2013. Cases were received on 21 March 2014. Three child patients whose demographic details, medical history and concomitant medication were not reported received a dose of FLUZONE ID on an unspecified date (route, site, dose and batch number not reported). It was reported that on an unspecified date patient received a vaccine of incorrect age. Laboratory investigation were not reported. No adverse event was reported. List of documents held by sender: None.
This spontaneous report as received from a physician via company representative refers to a one-hundred to more than one-hundred adolescent (exact age was not provided) female patients. Patient's medical history, concurrent conditions and drug reaction or allergies were not reported. On an unknown date, the patients were vaccinated with a dose of GARDASIL (dose, frequency, route of administration, indication and lot # were not reported). Concomitant medications were not reported. On an unknown date also reported as "several days after administration of unspecified dose of GARDASIL", the patients experienced fainting. On an unknown date, the patients were examined by unspecified local physicians which found that "there was nothing wrong with them". Product quality complaint (PQC) was not involved. The outcome of fainting was unspecified by the reporting physician. The relatedness between the event and GARDASIL was not reported. Additional information is not expected, as the reporting physician did not wish to be contacted.
11/15 arm began getting red and warm-area of redness was golf ball size-continued until 11/17 when only slightly red and no induration
soreness at injection site, golf ball size hard spot, redness, itching and hot to the touch. symptoms started in 1-3 days
Information has been received from a 25 year old female with a history of migraine who "in February or March, 2009", was vaccinated IM with the first dose of GARDASIL 0.5ml. On 14-JUL-2009 she got IM her second dose of GARDASIL 0.5ml. There were no concomitant medications. Afterwards the patient developed a headache. She said that she thought that the headache was more likely "due to stress than it was to the vaccine". No further information is available.
After receiving the 2nd dose of the shingles vaccine I experienced pain in my shoulder and my arm never got sore in the muscle like all of my previous vaccines.  I saw my primary physician in February 4th as my shoulder wasn't getting better and was getting worse.  My doctor referred me for physical therapy.  On March 15th, I saw my primary physician on March 15th who referred me to a shoulder specialist.   On April 15th, I had a MRI for my shoulder.  On April 26th I saw a shoulder specialist.  On May 17th I received a cortisone shot for my shoulder pain.  On June 17th, I had shoulder surgery.
Fever, mild swelling, red with mild edema; started the night after vaccine. Came to clinic 2 days, post vax, and was advised to use cold compresses every 3 hours for 15 minutes. Antibiotic started.
pt recv vax 15JUL96 & broke out w/ 20-30 lesions that looked like varicella lesions starting on 2AUG(6-on face, scalp, arms, trunk, legs lasted for 4-5 days;on fever or congestion;
Elevated temp all day 26 & 27JUL (After Tylenol was 102(ax) & 103(ax), irritable then became listless & tired - mom basically rocked him for 2 days.
Bleeding ulcers; This is a spontaneous report from a contactable consumer (patient).   A 70-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 06Mar2021 (Batch/Lot Number: EN6205) at the age of 70-years-old as single dose for covid-19 immunization. Medical history included a bariatric bypass surgery 15 years ago. the patient on unspecified date in Oct2021 had received flu vaccine and  It made his arm sore for 5 days . There were no concomitant medications. The patient had received the first dose of the same vaccine on 13Feb2021, from lot  EL9267. The patient experienced bleeding ulcers on Aug2021 with outcome of recovered.  The patient was hospitalized for bleeding ulcers, which currently he had to receive 2 blood transfusions in the hospital. Last week he took a blood sample that was taken by his GI doctor and it revealed he has no immunity or antibodies for the Covid 19 right now. He is also Covid negative when checked by hospital. The patient stated he no longer has bleeding ulcer, but has to be on a drug regimen for the next 3 months from the GI doctor and basically for the rest of his life be taking Omeprazole once daily to prevent and too much acid from building up or happening.
Vomiting; nausea; pounding headache; muscle aches; dizziness; chills; itching; mild rash; excessive mouth watering; This is a spontaneous report from a contactable consumer or other non hcp (patient) and physician. A 62-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch number/Lot number was not reported), via an unspecified route of administration, administered in arm left on 13Apr2021 at 09:00 AM (at the age of 62-year-old) as dose 2, single for COVID-19 immunization. The patient medical history included coronary artery disease, latex allergy. The patient received concomitant medications in two weeks which included celecoxib (CELEXA [CELECOXIB]), pravastatin sodium (PRAVACHOL), clonazepam (KLONOPIN), famotidine (PEPCID AC), hydroxyzine (ATARAX [HYDROXYZINE]) taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccine in four weeks. Patient did not have COVID prior to vaccination and no COVID tested post vaccination. The patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch number/Lot number was not reported), via an unspecified route of administration, administered in arm left on 23Mar2021 at 09:00 AM as dose 1, single for COVID-19 immunization. The patient previously took clindamycin, keflex [cefalexin monohydrate], penicillin and experienced allergy. On 13Apr2021 at 22:00 (10:00 PM), the patient experienced vomiting for 24 hours, nausea for 36 hours, pounding headache, muscle aches, dizziness, chills with 2nd dose. Itching, mild rash and excessive mouthwatering with both doses. Timeframe between vaccination and starting of symptoms was 13 hours. No treatment was received for the events. The clinical outcome of all the events was recovering.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
This case was reported by a other health professional via call center representative and described the occurrence of pain in arm in a 73-year-old male patient who received SHINGRIX for prophylaxis.  Co-suspect products included SHINGRIX for prophylaxis. On 19th June 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, the patient received the 3rd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX and not applicable after receiving SHINGRIX, the patient experienced pain in arm, circumstance or information capable of leading to medication error and extra dose administered. On an unknown date, the outcome of the pain in arm, circumstance or information capable of leading to medication error and extra dose administered were unknown. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: The healthcare professional reported that the patient believed that they received the first dose of SHINGRIX but there was no documented that the patient was given the vaccine. The facility was unsure if the patient actually received the first dose of SHINGRIX, but the patient reported that he experienced sore arm after potentially receiving the vaccine. The healthcare professional also reported that the patient had blood drawn on the same date. The healthcare professional reported that the patient may receive 3 doses of SHINGRIX if the dose was previously administered, which led to circumstance or information capable of leading to medication error for extra dose administered.
1 hr. post vaccine-extreme soreness at injection site. 4 hrs post vaccine-muscle aches, low fever (99°-100°), chills, fatigue. 18 hrs post vaccine-vaccine site pain, muscle aches (whole body), fever of 102°, chills, diarrhea, headache, extreme fatigue, dizziness, weakness 36 hrs post vaccine- vaccine site pain, muscle aches, fever of 101°, chills, worsening headache, dry cough, fatigue, dizziness, weakness. 56 hrs post vaccine-vaccine site still red and painful to the touch, but less pain than before, less headache, muscle pain, and fatigue, low fever 99.5°.
about 19 hours after the vaccine was received, I saw floaters in my eyes so badly that my vision was reduced by more than 50% (it happens frequently where I see floaters, but never even remotely this bad).  Became very disoriented & confused, had trouble processing things, had trouble talking, felt dizzy for about 30 minutes.   After 30 minutes, it slowly diminished and I felt more myself within an hour. (although still had the typical affects from the vaccine: bad nausea & fatigue, slight fever & aches).
Information was received on 20-JUL-2017 from a lawyer regarding a case in litigation concerning a female patient of unknown age. It is being claimed that the patients,  their physicians and their pharmacists use ZOSTAVAX vaccine in the manner in which it was intended. The patient was inoculated with a dose of ZOSTAVAX vaccine on or about 02-FEB-2011 at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent stain of herpes zoster. On or about 05-JAN-2013, the patient was treated at the emergency room for a painful and blistering vesicular outbreak which was diagnosed as herpes zoster or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages and required  extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. Additional information has been requested.
Nine days after receiving the rabies vaccine, donor developed soreness at the site of vaccination. He also developed a fever to 101.5, diarrhea, cough and congestion. These symptoms lasted for approximately four days.
Stomach cramps after eating/ Same foods would cause cramping one day and not the next but came back just as bad after second dose; Stomach cramps after eating/ Same foods would cause cramping one day and not the next; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via unspecified route of administration in the left arm on 20Apr2021 at 10:00 (at the age 33-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via unspecified route of administration in the left arm on 12May2021 at 11:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issues. The patient had no known allergies to medications, food or other products. Concomitant medication was not reported. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Apr2021, the patient experienced stomach cramps after eating and the same foods would cause cramping one day and not the next day. She further reported that the event subsided before second dose but came back just as bad after second dose. Therapeutic measures taken as a result of stomach cramps which included the prescription of pantoprazole (MANUFACTURER UNKNOWN). The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of stomach cramps with onset of 23Apr2021 was recovered on an unknown date in 2021, while outcome of stomach cramps with onset of second dose was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
tinnitus ongoing since 2 dose Pfizer covid vaccine; Other vaccine same date vaccine date: 05Jan2021; Other vaccine same date vaccine date: 05Jan2021; This is a spontaneous report from a contactable other health care professional reported for herself (Nurse). A 50-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date: not reported), via an unspecified route of administration, administered in Arm Left on 05Jan2021 (age at vaccination was 50 years) as dose number unknown, single and received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date: not reported), via an unspecified route of administration, administered in Arm Right on 05Jan2021 (age at vaccination was 50 years) as dose number unknown, single for COVID-19 immunization. Patient was not pregnant at the time of vaccination The patient's medical history included none. The patient did not have any known allergies. The patient did not receive any concomitant medications or other medications in two weeks. The facility where the most recent COVID-19 vaccine was administered was Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. On 05Jan2021 the patient experienced tinnitus ongoing since 2 doses pfizer covid vaccine and other vaccine was given on same day in both arms, vaccine date: 05Jan2021. The patient underwent lab tests and procedures which included PCR/Nasal Swab which showed negative result on 16Aug2021. No treatment was received for the adverse events. The outcome of the event tinnitus was not resolved. The outcome of rest of all events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
29 Pregnant female was vax /w MMR May90. In Aug90, fetal death was Dx. Pt hospitalized & underwent D&C. Pathology rpt revealed that gestational age of baby approx 12 wks @ time of death
Developed dizziness, nausea, blurred vision within an hour of getting vaccines - symptoms continued - employee was seen by provider in ED couple days later.
Spasm in middle back and upper arms sever pain. Pain persist to this day, makes for difficulty in getting up or out of chairs, bed, auto, dressing and walking, etc
Pericarditis    Treated in ER as heart attack but later found to be pericarditis.  Severe chest pain first treated with morphine, then with toroidal  (nsaid)  had CT , Echo EKG, all normal.
PATIENT STARTIED TO BREAK OUT IN HIVES ON FACE & CHEST UPON ARRIVAL AT HOME APPROX 30 MINS AFTER VACCINE. NO COUGH/WHEEZE/RESPIRATORY DISTREES/ FACILA EDMA. MOTHER ADMINISTERED BENADRYL ORALLY. HIVES RESOLVED WITHIN 45 MINS. PATIENT IS ALLERGIC TO SOY/PEANUTS
?Covid arm?- itchy welt appeared around injection site. Started off around 1? diameter when I noticed it 5-6 days after injection and has expanded to more than 4? (10 days post injection)
BREAKTHROUGH COVID INFECTION. PATIENT TESTED POSITIVE ON 10/01/2021. PATIENT WAS FULLY VACCINATED ON 03/19/2021.
This spontaneous report as received from a nurse refers to an unknown number of patients of unknown age and gender. On an unknown date, the patients were vaccinated with improperly doses of RECOMBIVAX HB Lot M046373, expiration date 04-NOV-2018. Administered doses of vaccines experienced the temperature excursion of 47 to 77 degrees Fahrenheit (53.4F) for 54 minutes. Data logger was involved. There were no previous excursions reported. No adverse effects were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1707USA007194: US-009507513-1707USA009211.
Within 2 weeks of shot, AFIB episodes increased in number, going from one ocassionally, to 2 within 2 weeks and then on April 2, 2021, they began to occur daily and last for 6-8 hours.  This continued for approximately 5 weeks after which they began to subside and now happen weekly at much shorter intervals
Patient developed edema and redness, (a hive-like area) next to site of injection within 5 minutes of injection. Ice applied to area and swelling went down signifigantly.
Information has been received from a registered nurse concerning a 13 year old male patient who on unspecified dates was vaccinated with the series of RECOMBIVAX HB. The nurse stated that the patient showed no hepatitis B antibodies in his bloodwork, despite completing the series of RECOMBIVAX HB. Additional information has been requested.